Among men on active surveillance or watchful waiting for low- and intermediate-risk prostate cancer (PCa), Blacks had a shorter median time from PCa diagnosis to definitive therapy compared with Whites.
Black and Hispanic patients were more likely to have COVID-19 but less likely to have an increase in telehealth visits.
Disparity not explained by underlying medical conditions or where they live or receive care.
Consistent underrepresentation seen in clinical trials evaluating medications across major cancer types.
Clinicians should consider whether a race correction will relieve or exacerbate inequities, according to editorialists.
The aim of this qualitative study was to explore the perspectives of clinical trial “stakeholders” regarding enrollment of minorities in cancer clinical trials.
White, black, and Hispanic patients have worse odds of cancer-specific and overall survival versus Asian patients.
A study of patients aged 70 or younger with high-risk prostate cancer found that black and Hispanic race was associated with a greater likelihood of receiving nondefinitive treatment, with patients experiencing poor outcomes as a result.
Mortality rates significantly higher for territory-dwelling Hispanic and Asian dialysis patients
Authors say efforts to maintain normal blood pressure may cut cardiovascular disease.
